文献速递胃肠外科

腹腔镜结肠癌切除治疗T4期病变的肿瘤学结局:7年病例对照分析

Oncologic outcomes following laparoscopic colon cancer resection for T4 lesions: a case-control analysis of 7-years' experience.
PubMed 文献 · Surg Endosc · 2017-08-25

该回顾性病例对照分析纳入2008年6月至2015年9月间147例组织学证实为pT4结肠癌并接受根治性整块切除的患者,比较腹腔镜与开腹手术的肿瘤学结局。腹腔镜组手术时间、出血量和住院时间显著减少,术后并发症率和30天死亡率无显著差异,R1切除率和淋巴结清扫数无显著差异,腹腔镜组中转率19%,中转不影响长期结局。两组5年总生存率和无病生存率无显著差异(44.6%和40.3% vs 39.4%和38.9%),局部晚期分期(IIIB-IIIC)和R1切除是总生存的独立预后因素。结论认为腹腔镜用于局部晚期结肠癌可能安全可接受,不损害肿瘤学结果,中转开腹不应影响围手术期和长期结局。

要点

  • 腹腔镜组手术时间、出血量和住院时间显著减少。
  • 两组术后并发症率、30天死亡率、R1切除率和淋巴结清扫数无显著差异。
  • 两组5年总生存率和无病生存率无显著差异(44.6%和40.3% vs 39.4%和38.9%)。

核心结论

  • 腹腔镜途径对局部晚期结肠癌可能安全可接受,不损害肿瘤学结果。
  • 中转开腹应作为策略的一部分,似乎不 adverse 影响围手术期和长期结局。
  • 在专家手中,腹腔镜可视为精选局部晚期结肠癌的最后诊断工具和首选治疗途径。

研究设计与样本

  • 回顾性病例对照分析,纳入2008年6月至2015年9月间147例组织学证实为pT4结肠癌并接受根治性整块切除的患者。

主要发现

  • 腹腔镜组中位手术时间、出血量和住院时间显著减少。
  • 两组术后手术并发症率和30天死亡率无显著差异(p=0.09和p=0.99)。
  • 两组R1切除率和淋巴结清扫数无显著差异。
  • 腹腔镜组中转率为19%,中转患者长期结局未受影响。
  • 两组5年总生存率和无病生存率无显著差异(44.6%和40.3% vs 39.4%和38.9%)。

临床怎么用

  • 对精选的局部晚期结肠癌,在专家手中可考虑腹腔镜整块切除。
  • 中转开腹应作为策略的一部分,不应因此否定腹腔镜途径。

局限性

  • 需要更大规模的前瞻性研究来广泛评估该问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: According to many Societies' guidelines, patients presenting with clinical T4 colorectal cancer should conventionally be approached by a laparotomy. Results of emerging series are questioning this attitude. METHODS: We retrospectively analysed the oncologic outcomes of 147 patients operated on between June 2008 and September 2015 for histologically proven pT4 colon cancers. All patients were treated with curative intent, either by a laparoscopic or open "en bloc" resection. RESULTS: Median operative time, blood loss and hospital length of stay were significantly reduced in the laparoscopic group. Postoperative surgical complication rate and 30-day mortality did not significantly differ between the two groups ( p = 0.09 and p = 0.99, respectively). R1 resection rate and lymph nodes harvest, as well, did not remarkably differ when comparing the two groups. In the laparoscopic group, conversion rate was 19%. Long-term outcomes were not affected in patients who had undergone conversion. Five-year overall survival and disease-free survival did not significantly differ between the two groups (44.6% and 40.3% vs. 39.4% and 38.9%). Locally advanced stages (IIIB-IIIC) and R1 resections were detected as independent prognostic factors for overall survival. CONCLUSION: Laparoscopic approach might be safe and acceptable for locally advanced colon cancer and does not jeopardize the oncologic results. Conversion to open surgery should be a part of a strategy as it does not seem to adversely affect perioperative and long-term outcomes. We consider laparoscopy, in expert hands, the last diagnostic tool and the first therapeutic approach for well-selected locally advanced colon cancers. Larger prospective studies are needed to widely assess this issue.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Leon P, Iovino MG, Giudici F, et al. Oncologic outcomes following laparoscopic colon cancer resection for T4 lesions: a case-control analysis of 7-years' experience. Surg Endosc. 2017. PMID: 28842796. doi:10.1007/s00464-017-5784-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。